C01EA01 - Alprostadil |
Not porphyrinogenic |
NP |
Rationale
Endogenous prostaglandin. No relevant CYP metabolism.
Chemical description
Prostaglandin E1.
Therapeutic characteristics
Alprostadil is used mainly in congenital heart disease and in erectile dysfunction.
Metabolism and pharmakokinetics
Metabolized in the lungs and excreted within 24 hours.
Preclinical data
None
Personal communication
None
Published experience
None
Similar drugs
© NAPOS 2024